Growth Metrics

Resmed (RMD) Operating Leases (2019 - 2025)

Historic Operating Leases for Resmed (RMD) over the last 7 years, with Q4 2025 value amounting to $154.1 million.

  • Resmed's Operating Leases rose 1076.04% to $154.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $154.1 million, marking a year-over-year increase of 1076.04%. This contributed to the annual value of $153.0 million for FY2025, which is 818.06% up from last year.
  • As of Q4 2025, Resmed's Operating Leases stood at $154.1 million, which was up 1076.04% from $147.8 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Operating Leases ranged from a high of $154.1 million in Q4 2025 and a low of $112.4 million during Q3 2023
  • Moreover, its 5-year median value for Operating Leases was $130.1 million (2021), whereas its average is $130.1 million.
  • In the last 5 years, Resmed's Operating Leases plummeted by 1242.76% in 2022 and then skyrocketed by 2849.49% in 2024.
  • Over the past 5 years, Resmed's Operating Leases (Quarter) stood at $133.0 million in 2021, then fell by 12.43% to $116.4 million in 2022, then increased by 20.79% to $140.6 million in 2023, then decreased by 1.06% to $139.2 million in 2024, then rose by 10.76% to $154.1 million in 2025.
  • Its Operating Leases stands at $154.1 million for Q4 2025, versus $147.8 million for Q3 2025 and $153.0 million for Q2 2025.